Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: Randomised controlled trial

British Medical Journal

Volumn 333, Issue 7568, 2006, Pages 571-574

  Diggle, Linda ^a   Deeks, Jonathan J ^b   Pollard, Andrew J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG DOSE REGIMEN; FOLLOW UP; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFLUENZA; INJECTION SITE ERYTHEMA; INJECTION SITE SWELLING; MENINGITIS; NEEDLE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TETANUS;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG ERUPTIONS; EQUIPMENT DESIGN; HAEMOPHILUS VACCINES; HUMANS; INFANT; NEEDLES; VACCINATION; VACCINES, COMBINED;

EID: 33748936477     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38906.704549.7C     Document Type: Article

References (15)

1. Department of Health. Immunisation against infectious diseases. London: HMSO, 1996.
2. Chief Medical Officer, Chief Nursing Officer, Chief Pharmaceutical Officer. Important changes to the childhood immunisation programme. London: Department of Health, 12 Jul 2006.
3. World Health Organization. Immunization in practice: module 6 holding an immunization session. WHO/IVB/04.06. www.who.int/vaccines-diseases/epitraining/ SiteNew/iip/PDF/Module6.pdf (accessed 20 Jul 2006.)
4. Weir DM, Stewart J. Immunology. 8th ed. Edinburgh: Churchill Livingstone, 1997.
5. Madore DV, Johnson Kraines CL, Rothstein EP, Smith DH. Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates. Curr Med Res Opin 1999;15:105-12.
6. Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Improving interpretation of clinical studies by use of confidence levels, clinical significance curves and risk-benefit contours. Lancet 2001;357:1349-53.
7. Mayon-White RT, Moreton J. Immunizing children - a practical guide. Oxford: Radcliffe Medical, 1997.
8. Watson M. Needle length and incidence of local reactions to immunization. Needle gauge is more important than needle length. BMJ 2001;322:492.
9. Mark A, Carlsson RM, Granstrom M. Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. Vaccine 1999;17:2067-72.
10. Ruben FL, Froeschle JE, Meschievitz C, Chen K, George J, Reeves-Hoche MK, et al. Choosing a route of administration for quadrivalent meningococcal polysaccharide vaccine: intramuscular versus subcutaneous. Clin Infect Dis 2001;32:170-2.
11. Zuckerman JN. The importance of injecting vaccines into muscle. Different patients need different needle sizes. BMJ 2000;321:1237-8.
12. Bernier RH, Frank JA Jr, Nolan TF Jr. Abscesses complicating DTP vaccination. Am J Dis Child 1981;135:826-8.
13. Hick JF, Charboneau JW, Brakke DM, Goergen B. Optimum needle length for diphtheria-tetanus-pertussis inoculation of infants. Pediatrics 1989;84:136-7.
14. Shaw FE Jr, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989;7:425-30.
15. Reid Sanden FL, Fishbein DB, Stevens CA, Briggs DJ. Administration of rabies vaccine in the gluteal area: a continuing problem. Arch Intern Med 1991;151:821.